NovaBay Pharmaceuticals, Inc. 5Y Shareholders Equity Growth (per Share)

5Y Shareholders Equity Growth (per Share) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including 5Y Shareholders Equity Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 5Y Shareholders Equity Growth (per Share) for 2021 was -20.95% (a -Infinity% decrease from previous year)
  • Annual 5Y Shareholders Equity Growth (per Share) for 2020 was 0.0% (a -100.0% decrease from previous year)
  • Annual 5Y Shareholders Equity Growth (per Share) for 2019 was -45.44% (a 2.04% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 5Y Shareholders Equity Growth (per Share) of NovaBay Pharmaceuticals, Inc.

Most recent 5Y Shareholders Equity Growth (per Share)of NBY including historical data for past 10 years.

Interactive Chart of 5Y Shareholders Equity Growth (per Share) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. 5Y Shareholders Equity Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -20.95%
2020 0.0%
2019 -45.44%
2018 -44.53%
2017 -57.3%
2016 -39.17%
2015 0.0%
2014 83.29%
2013 80.29%
2012 134.19%
2011 64.4%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology